Polyneuropathy: Diagnosis and management;Polyneuropathie: Diagnostiek en beleid

Nederlands Tijdschrift voor Geneeskunde

Volumn 141, Issue 48, 1997, Pages 2327-2333

  Notermans, N C ^a   Van Doorn, P A ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; NERVE FIBER REGENERATION; POLYNEUROPATHY; REMYELINIZATION; REVIEW;

ALGORITHMS; AUTOIMMUNE DISEASES; DEMYELINATING DISEASES; FEMALE; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; INFECTION; MALE; METABOLIC DISEASES; MIDDLE AGED; NERVE DEGENERATION; NEUROLOGIC EXAMINATION; POLYNEUROPATHIES;

EID: 6844237684     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Notermans NC, Wokke JHJ, Jennekens FGI. Clinical work-up of the patient with a polyneuropathy. In: Jong JMBV de, Vinken PJ, Bruyn GW, Klawans HL, editors. Handbook of clinical neurology. Hereditary neuropathies and spinocerebellar atrophies. Amsterdam: Elsevier Science, 1991;16:30-70.
2. McLeod JG. Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1995;58:274-83.
3. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II Brain 1980;103:259-80.
4. Vos PE, Wokke JHJ. Spierkrampen en fasciculaties zijn niet altijd omineus: het spierkramp-fasciculatiesyndroom. Ned Tijdschr Geneeskd 1996;140:1655-8.
5. Donofrio PD, Albers JW. AAEM minimonograph :34: polyneuropathy: classification by nerve conduction studies and electromyography. Muscle Nerve 1990;13:889-903.
6. Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 1985;108 (Pt 4):861-80.
7. Ropper AH. Accelerated neuropathy of renal failure. Arch Neurol 1993;50:536-9.
8. Behse F, Buchthal F. Alcoholic neuropathy: clinical, electrophysiological and biopsy findings, Ann Neurol 1977;2:95-110.
9. Enting RH, Portegies P, Vermeulen M. Neuropathieën in het beloop van de HIV-infectie. Ned Tijdschr Geneeskd 1992;136:2361-5.
10. Hoogendijk JE, Baas F, Visser M de, Bolhuis PA. Duplicatie van DNA bij hereditaire motorische en sensibele neuropathie (ziekte van Charcot-Marie-Tooth) type Ia. Ned Tijdschr Geneeskd 1991; 135:2412-4.
11. Kulkens T, Bolhuis PA, Wolterman RA, Kemp S, te Nijenhuis S, Valentijn LJ, et al. Depletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type IB. Nature Genet 1993;5:35-9.
12. Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993;72:143-51.
13. Hawke SHB, Davies L, Pamphlett R, Guo YP, Pollard JD, McLeod JG. Vasculitic neuropathy. A clinical and pathological study. Brain 1991;114(Pt 5):2175-90
14. Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain 1987;110(Pt 4):843-53.
15. Meché FGA van der, Doom PA van. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Immune mechanisms and update on current therapies. Ann Neurol 1995;37:S14-31.
16. Meché FGA van der, Schmitz PIM. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med 1992;326:1123-9.
17. The Dutch Guillain-Barré Study Group. Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994,35:749-52.
18. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculopathy. A clinical and electrophysiological study of 92 cases. Brain 1987;110(Pt 6):1617-30
19. Doom PA van, Brand A, Strengers PFW, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study. Neurology 1990;40:209-12
20. Kornberg AJ, Pestronk A. Chronic motor neuropathies. Diagnosis, therapy, and pathogenesis. Ann Neurol 1995;37:S43-50.
21. Latov N. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 1995;37:S32-42.
22. Notermans NC. Monoclonal gammopathy and neuropathy. Curr Opin Neurol 1996;9:334-7.
23. Notermans NC, Lokhorst HM, Franssen H, Graaf Y van der, Teunissen LL, Jennekens FGI, et al. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology [ter perse].
24. Graus F, Elkon KB, Cordon-Cardo C, Posner JB. Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor. Am J Med 1986,80.45-52.
25. Quesne PM Neuropathy due to drugs. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia: Saunders, 1993;86:1571-81.
26. Tuszynski MH, Gage FH. Neurotrophic factors and diseases of the nervous system. Ann Neurol 1994;35 Suppl:S9-12.
27. Notermans NC, Wokke JHJ, Franssen H, Vermeulen M, Busch HFM, Jennekens FGI. Beloop van chronische idiopathische polyneuropathie op middelbare of oudere leeflijd: 2 jaar follow-up-onderzoek. Ned Tijdschr Geneeskd 1994;138:1281-5.
28. Leijten FSS, Weerd AW de. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg 1994;96:10-9.